Diversity, Equity and Inclusion:
As members of PhRMA, we believe improving human life means celebrating human diversity
Diversity, Inclusion & Belonging
“While we are only one company, and in the big picture we play a small role, we know it will take all of us – across companies, communities, and cultures – to come together to make progress toward a more inclusive and equitable world.”– Richard Pops, Alkermes Chief Executive Officer
Gender Pay Equity
As of year-end 2021, median compensation for males and females at Alkermes was substantially equal across metrics of base salary, total cash compensation, and total compensation including equity. Minimizing gender pay disparities has been a priority for Alkermes, and we monitor our pay practices and make focused adjustments to maintain equitable pay across our employee population.
Supporting Diversity in Leadership
Developing a diverse leadership team is an important element of our success and we are proud to support and invest in diversity at all levels of the organization, including in leadership roles. We have made substantial progress in the area of gender diversity in the last four years, with significant gains in the percentages of women in senior roles, including an increase in the percentage of female employees on our management team from 14% in 2017 to 26% at year-end 2021.
Environmental Sustainability:
As members of PhRMA, we believe a healthy environment is essential for improving human life
Energy Usage
Energy usage per floor area (kWhr/m2) in 2021 was 21% lower than our 2015 baseline measurement year.
Waste Optimization
96% of total hazardous waste generated in 2020 was either recycled or processed in waste-to-energy
facilities.
Product Stewardship and Environmental Impact
Alkermes is committed to the safe and sustainable research, development, manufacturing, and commercialization of medicines. Our approach to product stewardship oversight and control includes development of “green chemistry” processes to eliminate or reduce the use or generation of hazardous substances in the design and manufacture of our products.
Access & Affordability:
As members of PhRMA, we believe that living our mission of improving human life relies on broad access to medicines
Pathways
The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience. The Alkermes Pathways Research Awards® program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to schizophrenia or bipolar disorder.
Access
We offer programs, such as our Patient Assistance Program and our Co-Pay Savings Program, to provide support to eligible patients who are prescribed our medicines. In 2021, more than 20,000 patients participated in our Co-Pay Savings Program.